These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1263 related articles for article (PubMed ID: 21836495)

  • 21. Genetic and pathologic characteristics of gastrointestinal stromal tumors in extragastric lesions.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Mol Med; 2006 Dec; 18(6):1067-71. PubMed ID: 17089009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
    Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
    Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
    Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
    J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation.
    Long KB; Butrynski JE; Blank SD; Ebrahim KS; Dressel DM; Heinrich MC; Corless CL; Hornick JL
    Am J Surg Pathol; 2010 Jun; 34(6):907-12. PubMed ID: 20442644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.
    Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M
    Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors.
    Agaram NP; Baren A; Arkun K; Dematteo RP; Besmer P; Antonescu CR
    Ultrastruct Pathol; 2006; 30(6):443-52. PubMed ID: 17182437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study.
    Muenst S; Thies S; Went P; Tornillo L; Bihl MP; Dirnhofer S
    Hum Pathol; 2011 Dec; 42(12):1849-54. PubMed ID: 21658742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
    J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
    Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series.
    Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM
    J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors.
    Barreca A; Fornari A; Bonello L; Tondat F; Chiusa L; Lista P; Pich A
    Mol Med Rep; 2011; 4(1):3-8. PubMed ID: 21461555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors.
    Holden JA; Willmore-Payne C; Coppola D; Garrett CR; Layfield LJ
    Am J Clin Pathol; 2007 Aug; 128(2):230-8. PubMed ID: 17638656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
    Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
    J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIT and PDGFRalpha mutational analyses of mixed cell-type gastrointestinal stromal tumours.
    Wong NA; Mangwana S
    Histopathology; 2007 Dec; 51(6):758-62. PubMed ID: 18042065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIT-positive gastrointestinal stromal tumor in a 22-year-old male chimpanzee (Pan troglodites).
    Saturday GA; Lasota J; Frost D; Brasky KB; Hubbard G; Miettinen M
    Vet Pathol; 2005 May; 42(3):362-5. PubMed ID: 15872385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.
    Sápi Z; Füle T; Hajdu M; Matolcsy A; Moskovszky L; Márk A; Sebestyén A; Bodoky G
    Diagn Mol Pathol; 2011 Mar; 20(1):22-33. PubMed ID: 21326036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
    Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM
    Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.